Doctors will choose one or the other based on the patients specific condition
That means there are no standardized, official dosing guidelines for obesity outcomes, and products sold in the market may not meet pharmaceutical-level quality controls
The consultation included an honest discussion of where the evidence was strong (topical applications, tissue repair contexts) and where it was thinner (systemic injectable use for aesthetic outcomes)
Always talk to your healthcare provider to see if theyre right for you.
Demonstrates BPC-157 effects on muscle repair and angiogenesis in animal studies
Monitoring schedule Healthcare providers who specialize in GLP-1 therapy typically recommend this monitoring cadence: Baseline: Full B12 panel before starting semaglutide 3 months: Repeat serum B12 and MMA 6 months: Full panel reassessment Annually: Once stable, annual monitoring is usually sufficient For high-risk patients (metformin users, vegans, those over 60, post-bariatric surgery), the 3-month check is particularly important